Bibliography
- Pestronk A, Cornblath DR, Ilyas A, A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-8
- van Schaik IN, Bouche P, Illa I, European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol 2006;13:802-8
- Nobile-Orazio E, Cappelari A, Priori A. Multifocal motor neuropathy: currents concepts and controversies. Muscle Nerve 2005;31:663-80
- Abhinav K, Stanton B, Johnston C, Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology 2007;29:44-8
- van Schaik IN, Eftimov F. Immunotherapy of multifocal motor neuropathy. Expert Opin Biol Ther 2011;11:xxx-xxx
- Cats EA, van der Pol WL, Piepers S, Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 2010;75:818-25
- Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007;69:1680-7
- Terenghi F, Cappellari A, Bersano A, How long is IVIg effective in multifocal motor neuropathy? Neurology 2004;62:666-8
- Vucic S, Black KR, Chong PST, Cros D. Multifocal motor neuropathy. Decrease in conduction blocks and reinnervation with long-term IVIg. Neurology 2004;63:1264-9
- Baumann A, Hess CW, Sturzenegger M. IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up. J Neurol 2009;256:608-14
- Caress JB, Hobson-Webb L, Passmore LV, Case-control study of thromboembolic events associated with IV immunoglobulin. J Neurol 2009;256:339-42
- Piepers S, Van den Bergh-Vos R, Van der Pol WR, Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain 2007;130:2004-10
- Chaudhry V, Cornblath DR. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy. J Peripher Nerv Syst 2010;15:196-201
- Carson KR, Evens AM, Richey EA, Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009;113:4834-40
- RMC Trial Group. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 2009;8:158-64
- Rajabally YA, Seow H, Wilson P. Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2006;11:325-9